| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |